Curovir utvecklar nya antivirala läkemedel mot enterovirus (inklusive rhinovirus) som årligen uppskattas orsaka mer än en miljard infektioner. Enterovirus orsakar vanligtvis milda infektioner så som vanlig förkylning men de kan även orsaka svåra infektioner, främst hos vissa grupper tex nyfödda barn, äldre och patienter med immunbrist eller andra underliggande sjukdomar tex astma eller kronisk obstruktiv lungsjukdom.
Company Details
- Employees
- 2
- Founded
- -
- Address
- Kalmar, Se
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- http://www.curovir.com
- HQ
- Kalmar
Curovir Ab Questions
Curovir Ab's website is http://www.curovir.com
Curovir Ab's LinkedIn profile is https://se.linkedin.com/company/curovir-ab
Curovir Ab has
2 employees.
View email and phone details for 2
employees at Curovir Ab.
Curovir Ab's industry is
Research Services
Curovir Ab's top competitors are
Simplexia,
Gesynta Pharma Ab,
Apodemus Ab,
Elicera Therapeutics Ab,
Coegin Pharma Ab,
Ab Cernelle,
Combigene,
Chosa Oncology,
Cereno Scientific,
Cross Pharma.
Curovir Ab's categories are Research Services
Curovir Ab's founding year is 2017
